FDA approves sleep apnea tech from EnsoData, Samsung

Efforts to improve sleep apnea diagnosis and treatment are increasing, considering that approximately 39 million US adults and over 936 million individuals globally suffer from it. Health tech firms are focusing on leveraging algorithms, machine learning, and wearable sensors for improved care. Recent innovations include an FDA-approved AI algorithm from EnsoData for sleep disorder diagnosis and a Samsung Galaxy Watch feature to guide patients to sleep studies. Federal agencies have reported recall-related deaths for PAP machines, and Mount Sinai has been grante a $4.1 million grant to develop AI for patient risk profiling.